Delivery Order SPE2DB20D2014-SPE2DB24FC65B

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.10 firm fixed-price contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has a period of performance through February 5, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.76 firm fixed-price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has a performance period through May 22, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a ceiling value of $1,048.00. The contract is a firm fixed price, non-set-aside delivery order with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has a ceiling value of $1,200.80 and an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a $1,853.75 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of June 26, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a $2,096 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a period of performance through April 9, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order valued at $2,269.70 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of July 3, 2025. The contract is a Firm Fixed Price type and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a ceiling value of $1,390.52 and a completion date of March 6, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a $3,405.45 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a ceiling value of $1,048.00. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC65B
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $4,647.48 firm-fixed-price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of critical pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs nationwide. This contract award is not associated with a set-aside program.

Generated 11/1/24, 9:20 AM